VREX Stock Analysis: Buy, Sell, or Hold?
VREX - Varex Imaging Corporation Common Stock
$10.80
-0.25 (-2.26%)
▼
5d:
+0.56%
30d:
+2.56%
90d:
-3.4%
BUY
HIGH Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When VREX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VREX appears deeply undervalued. Market expects -5.1% annual earnings decline despite 453% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: VREX appears deeply undervalued. Market expects -5.1% annual earnings decline despite 453% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.66
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.31
29.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VREX is currently trading at $10.80, which is considered slightly high relative to its 30-day fair value range of $10.27 to $10.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.2) compared to its historical average (11.9). Remarkably, the market is currently pricing in an annual earnings decline of 5.1% over the next few years. This pessimistic expectation contrasts with the company's recent 453.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VREX is in a downtrend. Immediate support is located at $9.59, while resistance sits at $11.23.
Market Sentiment: VREX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VREX is in a downtrend. Immediate support is located at $9.59, while resistance sits at $11.23.
Market Sentiment: VREX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$10.27 -
$10.82
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 66.7% below Wall St target ($18.00)
Trading Range Analysis
30-Day Trading Range
$10.27 -
$10.82
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.59
Resistance Level
$11.23
Current Trend
Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.15
Wall Street Target
$18.00
(+66.7%)
Revenue Growth (YoY)
1.5%
Earnings Growth (YoY)
453.4%
Profit Margin
-9.6%
Valuation Discount vs History
-5.1% cheaper
PE vs Historical
10.2 vs 11.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.1%
(market-implied from PE analysis)
1-Year Target
$10.25
(-5%)
2-Year Target
$9.73
(-10%)
3-Year Target
$9.23
(-15%)
3-Yr Target (if PE normalizes)
(PE: 10→12)
$10.82
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 36.8%)
$59.28
(+449%)
Base:
(SPY PE: 10.2, Growth: 36.8%)
$27.63
(+156%)
Bear:
(PE: 8.6, Growth: 36.8%)
$23.48
(+117%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.2 to 11.9
Stabilization Target:
$12.66
(+17.2%)
PE Expansion Potential:
+17.2%
Share & Embed Analysis
Last updated: July 14, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
Data refreshes hourly during market hours. Next update: 1:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VREX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jay K Kunkel
SELL
4510 shares
2026-03-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 57 HOLD |
